Probiotics and aging: Impacts on cognitive function, brain-derived neurotrophic factor, inflammation, and antioxidant activity. A systematic review and meta-analysis
- 2 February 2026
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 110 (2) , 545-558
Abstract
Background: Cognitive decline represents a major challenge in aging populations. Probiotics have been proposed to influence cognitive function through gut–brain interactions, but clinical findings remain inconsistent. Objective: This study evaluated the effects of probiotic supplementation on cognitive function as the primary outcome, and on BDNF levels, inflammatory markers, and oxidative stress biomarkers as secondary outcomes in adults aged 50 years and older. Methods: A systematic search of PubMed, EBSCO, ProQuest, and Google Scholar was conducted through 1 May 2024 using predefined search terms related to probiotics, cognitive function, BDNF, inflammation, and antioxidant activity. Study quality was assessed using the RoB 2 tool. Meta-analyses were performed using random-effects models, and publication bias was explored using Egger's test where study counts permitted. Results: Sixteen studies demonstrated significant improvement in cognitive function among participants receiving probiotics compared to placebo. Cognitive function, measured using the Mini-Mental State Examination (MMSE), yielded a standardized mean difference (SMD) of 0.747 (95% CI 0.307–1.186) which corresponds to moderate-to-large effects. In comparison, the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) showed significant results with an SMD of 0.340 (95% CI 0.032–1.366) which corresponds to small-to-moderate effects. Probiotics also led to significant changes in several biochemical parameters, including BDNF, TNF-α, 8-OHdG, IL-6, IL-10, MDA, TAC, and GSH. Multi-strain probiotics showed better results compared to single-strain. Conclusions: Probiotic supplementation may offer modest cognitive benefits in aging populations, particularly in studies enrolling cognitively impaired individuals, but substantial heterogeneity and limited biomarker evidence restrict the certainty of these findings. Larger, longer-duration, and standardized trials are needed to clarify the clinical relevance and potential biological pathways underlying probiotic effects on cognition.Keywords
This publication has 68 references indexed in Scilit:
- The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled studyInflammopharmacology, 2024
- Alzheimer’s Disease: Epidemiology and Clinical ProgressionNeurology and Therapy, 2022
- The estimation of the global prevalence of dementia from 1990‐2019 and forecasted prevalence through 2050: An analysis for the Global Burden of Disease (GBD) study 2019Alzheimer's & Dementia, 2021
- BDNF signaling in context: From synaptic regulation to psychiatric disordersCell, 2021
- Inflammaging, hormesis and the rationale for anti-aging strategiesAgeing Research Reviews, 2020
- Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease SpecificityDigestive Diseases and Sciences, 2020
- Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trialClinical Nutrition, 2019
- The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trialsEuropean Journal of Nutrition, 2019
- The gut-brain axis in Parkinson's disease: Possibilities for food-based therapiesEuropean Journal of Pharmacology, 2017
- Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiomeMovement Disorders, 2017